Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TBCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ECI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMTOR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM208 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF428 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMBIM6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CISD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITPNC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXN3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
H2AFY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GATC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHBP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIABLO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDAH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on